G. M. Tozer - Concepedia

Author

G. M. Tozer

Mount Vernon Hospital

Also Known As

G M Tozer, G. M. Tozer, G. Tozer, G.M. Tozer, Gillian M. Tozer

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Mount Vernon Hospital Hammersmith Hospital

About

G. M. Tozer is an author at Mount Vernon Hospital specializing in medicine, tumor biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.3K
2	Cell Biology	4	4	1.1K
3	Natural Sciences	1	1	87
4	Biochemistry	1	1	91
5	Molecular Biology	1	1	87

G. M. Tozer

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. G. Dark, S A Hill, Vivien E. Prise, PubMed Vascular ShutdownTumor BiologyOncologyCancer Cell BiologySelective Toxicity	1997	624
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. G. M. Tozer, Vivien E. Prise, John Wilson, PubMed Quantitative AutoradiographyPathologyTumor BiologyBlood FlowAngiogenesis	1999	324
An assessment of <sup>31</sup>P MRS as a method of measuring pH in rat tumours Marion Stubbs, Zaver M. Bhujwalla, G. M. Tozer, NMR in Biomedicine Extracellular ComponentsPathologyTumor BiologyOncologyGenitourinary Cancer	1992	145
Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography Steven A. Everett, Madeleine F. Dennis, G. M. Tozer, Journal of Chromatography A Biological FluidsBiochemistryReactive Nitrogen SpecieNitric OxideBioanalysis	1995	91
Limitations of the reporter green fluorescent protein under simulated tumor conditions. C Coralli, Maja Čemažar, Chryso Kanthou, PubMed Oncologic ImagingMolecular BiologyCellular Gfp FluorescenceCancer BiologyTumor Biology	2001	87
Combretastatin A-4, an agent that displays selective toxicity towards tumour vasculature D J Chaplin, S. Prise, G. M. Tozer, European Journal of Cancer Tumor BiologyTumour VasculatureMalignant DiseaseMedicinePathology	1997	22
The Influence of Nitric Oxide on Tumour Vascular Tone G. M. Tozer, Vivien E. Prise, Katrina M. Bell Acta Oncologica	1995	21
The combined measurement of blood flow and metabolism in RIF‐1 tumours <i>in vivo</i>. A study using H<sub>2</sub> flow and <sup>31</sup>P NMR spectroscopy Zaver M. Bhujwalla, G. M. Tozer, S. B. Field, NMR in Biomedicine	1990	17
The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification Maja Čemažar, Ian A. Wilson, Vivien E. Prise, British Journal of Cancer AngiogenesisTumour LinesMedicinePhysiologyEndothelial Dysfunction	2005	12

Page 1